Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score–matched real-world study accounting for poor prognostic factors
Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score–matched real-world study accounting for poor prognostic factors. // Annals of the Rheumatic Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S000349672600213X?dgcid=rss_sd_all
Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score–matched real-world study accounting for poor prognostic factors. Annals of the Rheumatic Diseases. https://www.sciencedirect.com/science/article/pii/S000349672600213X?dgcid=rss_sd_all
“Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score–matched real-world study accounting for poor prognostic factors.” Annals of the Rheumatic Diseases.
@article{article116435,
title = {Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score–matched real-world study accounting for poor prognostic factors},
journal = {Annals of the Rheumatic Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S000349672600213X?dgcid=rss_sd_all}
}